These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 33324345

  • 21. Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease.
    Soronen J, Yki-Järvinen H, Zhou Y, Sädevirta S, Sarin AP, Leivonen M, Sevastianova K, Perttilä J, Laurila PP, Sigruener A, Schmitz G, Olkkonen VM.
    Physiol Rep; 2016 Jan; 4(1):. PubMed ID: 26733244
    [Abstract] [Full Text] [Related]

  • 22. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
    Di Mauro S, Ragusa M, Urbano F, Filippello A, Di Pino A, Scamporrino A, Pulvirenti A, Ferro A, Rabuazzo AM, Purrello M, Purrello F, Piro S.
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
    [Abstract] [Full Text] [Related]

  • 23. Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway.
    Teimouri M, Hosseini H, Shabani M, Koushki M, Noorbakhsh F, Meshkani R.
    IUBMB Life; 2020 Mar; 72(3):361-372. PubMed ID: 31889412
    [Abstract] [Full Text] [Related]

  • 24. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X, Chen S, Zhang L.
    Am J Physiol Endocrinol Metab; 2020 Jul 01; 319(1):E34-E42. PubMed ID: 32228319
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
    Zhang H, Shen Z, Lin Y, Zhang J, Zhang Y, Liu P, Zeng H, Yu M, Chen X, Ning L, Mao X, Cen L, Yu C, Xu C.
    J Biol Chem; 2020 Mar 20; 295(12):3891-3905. PubMed ID: 32051143
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1.
    Jiang F, Chen Q, Wang W, Ling Y, Yan Y, Xia P.
    J Hepatol; 2020 Jan 20; 72(1):156-166. PubMed ID: 31568800
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD.
    Zhu M, Wang Q, Zhou W, Liu T, Yang L, Zheng P, Zhang L, Ji G.
    Sci Rep; 2018 May 16; 8(1):7628. PubMed ID: 29769539
    [Abstract] [Full Text] [Related]

  • 33. Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease.
    Feng YY, Xu XQ, Ji CB, Shi CM, Guo XR, Fu JF.
    Cell Physiol Biochem; 2014 May 16; 34(6):1983-97. PubMed ID: 25562147
    [Abstract] [Full Text] [Related]

  • 34. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG, An XS.
    Biochem Biophys Res Commun; 2018 Apr 06; 498(3):416-423. PubMed ID: 29454967
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1.
    Hu Y, Ye H, Shi LX.
    Eur Rev Med Pharmacol Sci; 2019 Nov 06; 23(22):10072-10082. PubMed ID: 31799678
    [Abstract] [Full Text] [Related]

  • 36. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X, Wang Z, Klaunig JE.
    Toxicology; 2019 Mar 15; 416():1-14. PubMed ID: 30711707
    [Abstract] [Full Text] [Related]

  • 37. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
    Chenxu G, Minxuan X, Yuting Q, Tingting G, Jing F, Jinxiao L, Sujun W, Yongjie M, Deshuai L, Qiang L, Linfeng H, Xuyuan N, Mingxing W, Ping H, Jun T.
    Free Radic Biol Med; 2019 Apr 15; 134():23-41. PubMed ID: 30599260
    [Abstract] [Full Text] [Related]

  • 38. Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance.
    Sud N, Zhang H, Pan K, Cheng X, Cui J, Su Q.
    J Nutr Biochem; 2017 May 15; 43():125-131. PubMed ID: 28284064
    [Abstract] [Full Text] [Related]

  • 39. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance.
    Meroni M, Longo M, Erconi V, Valenti L, Gatti S, Fracanzani AL, Dongiovanni P.
    Nutrients; 2019 Oct 29; 11(11):. PubMed ID: 31671785
    [Abstract] [Full Text] [Related]

  • 40. Exercise-Induced ADAR2 Protects against Nonalcoholic Fatty Liver Disease through miR-34a.
    Wang Z, Zhu Y, Xia L, Li J, Song M, Yang C.
    Nutrients; 2022 Dec 27; 15(1):. PubMed ID: 36615779
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.